Tags : i-DPS Technology

Anaeropharma Science and Astellas Pharma Collaborates to Develop Novel Anti-Tumor

Shots: Collaboration is for development of novel drugs utilizing B. longum as a drug delivery carrier for in-situ Delivery and Production System (i-DPS) Technology. Astellas has option rights to further develop and commercialize the develop product Anaeropharma has developed APS001F, a recombinant Bifidobacterium expresses Cytosine Deaminase which converts a prodrug, 5-FC, to an anti-cancer drug, […]Read More